nodes	percent_of_prediction	percent_of_DWPC	metapath
Tenoxicam—PTGS2—melanoma	0.703	1	CbGaD
Tenoxicam—SLC22A8—optic choroid—melanoma	0.0106	0.227	CbGeAlD
Tenoxicam—Gastrointestinal perforation—Docetaxel—melanoma	0.00598	0.032	CcSEcCtD
Tenoxicam—PTGS2—leg—melanoma	0.00535	0.114	CbGeAlD
Tenoxicam—PTGS2—hindlimb—melanoma	0.00478	0.102	CbGeAlD
Tenoxicam—PTGS2—appendage—melanoma	0.0041	0.0873	CbGeAlD
Tenoxicam—PTGS2—skin epidermis—melanoma	0.00341	0.0727	CbGeAlD
Tenoxicam—Toxic epidermal necrolysis—Vemurafenib—melanoma	0.003	0.0161	CcSEcCtD
Tenoxicam—Photosensitivity reaction—Vemurafenib—melanoma	0.00263	0.0141	CcSEcCtD
Tenoxicam—PTGS1—endothelium—melanoma	0.00259	0.0552	CbGeAlD
Tenoxicam—Stevens-Johnson syndrome—Vemurafenib—melanoma	0.00255	0.0136	CcSEcCtD
Tenoxicam—PTGS2—endothelium—melanoma	0.00248	0.0527	CbGeAlD
Tenoxicam—Lornoxicam—PTGS2—melanoma	0.00245	0.374	CrCbGaD
Tenoxicam—PTGS1—blood vessel—melanoma	0.00239	0.0509	CbGeAlD
Tenoxicam—PTGS2—blood vessel—melanoma	0.00228	0.0486	CbGeAlD
Tenoxicam—Erythema multiforme—Vemurafenib—melanoma	0.00218	0.0117	CcSEcCtD
Tenoxicam—Eye disorder—Vemurafenib—melanoma	0.00216	0.0115	CcSEcCtD
Tenoxicam—SLC22A8—eye—melanoma	0.00214	0.0456	CbGeAlD
Tenoxicam—Cardiac disorder—Vemurafenib—melanoma	0.00214	0.0115	CcSEcCtD
Tenoxicam—Angiopathy—Vemurafenib—melanoma	0.00209	0.0112	CcSEcCtD
Tenoxicam—Malnutrition—Vemurafenib—melanoma	0.00201	0.0108	CcSEcCtD
Tenoxicam—Erythema—Vemurafenib—melanoma	0.00201	0.0108	CcSEcCtD
Tenoxicam—Gastrointestinal haemorrhage—Carmustine—melanoma	0.00176	0.00944	CcSEcCtD
Tenoxicam—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.0017	0.00909	CcSEcCtD
Tenoxicam—Toxic epidermal necrolysis—Dactinomycin—melanoma	0.0017	0.00909	CcSEcCtD
Tenoxicam—Anaphylactic shock—Vemurafenib—melanoma	0.00164	0.00878	CcSEcCtD
Tenoxicam—Nervous system disorder—Vemurafenib—melanoma	0.00161	0.00861	CcSEcCtD
Tenoxicam—Skin disorder—Vemurafenib—melanoma	0.00159	0.00852	CcSEcCtD
Tenoxicam—Meloxicam—PTGS2—melanoma	0.00156	0.237	CrCbGaD
Tenoxicam—Breast disorder—Temozolomide—melanoma	0.00154	0.00825	CcSEcCtD
Tenoxicam—Acute coronary syndrome—Bleomycin—melanoma	0.00153	0.00822	CcSEcCtD
Tenoxicam—Toxic epidermal necrolysis—Temozolomide—melanoma	0.00153	0.00822	CcSEcCtD
Tenoxicam—Myocardial infarction—Bleomycin—melanoma	0.00153	0.00817	CcSEcCtD
Tenoxicam—Stomatitis—Bleomycin—melanoma	0.00152	0.00813	CcSEcCtD
Tenoxicam—Colitis—Docetaxel—melanoma	0.0015	0.00803	CcSEcCtD
Tenoxicam—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.00144	0.00771	CcSEcCtD
Tenoxicam—Decreased appetite—Vemurafenib—melanoma	0.00142	0.00763	CcSEcCtD
Tenoxicam—Stomatitis—Dactinomycin—melanoma	0.00141	0.00758	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Vemurafenib—melanoma	0.00141	0.00758	CcSEcCtD
Tenoxicam—Fatigue—Vemurafenib—melanoma	0.00141	0.00757	CcSEcCtD
Tenoxicam—Constipation—Vemurafenib—melanoma	0.0014	0.0075	CcSEcCtD
Tenoxicam—Agranulocytosis—Dactinomycin—melanoma	0.00135	0.00726	CcSEcCtD
Tenoxicam—Piroxicam—PTGS2—melanoma	0.00135	0.206	CrCbGaD
Tenoxicam—Photosensitivity reaction—Temozolomide—melanoma	0.00134	0.0072	CcSEcCtD
Tenoxicam—Stomatitis—Carmustine—melanoma	0.00132	0.00709	CcSEcCtD
Tenoxicam—Hepatitis—Dactinomycin—melanoma	0.0013	0.00698	CcSEcCtD
Tenoxicam—Stevens-Johnson syndrome—Temozolomide—melanoma	0.0013	0.00697	CcSEcCtD
Tenoxicam—Stomatitis—Temozolomide—melanoma	0.00128	0.00685	CcSEcCtD
Tenoxicam—Hepatobiliary disease—Temozolomide—melanoma	0.00124	0.00665	CcSEcCtD
Tenoxicam—Erythema multiforme—Dactinomycin—melanoma	0.00123	0.0066	CcSEcCtD
Tenoxicam—Erythema—Bleomycin—melanoma	0.00122	0.00651	CcSEcCtD
Tenoxicam—SLC22A8—head—melanoma	0.00122	0.0259	CbGeAlD
Tenoxicam—Hypersensitivity—Vemurafenib—melanoma	0.00121	0.00647	CcSEcCtD
Tenoxicam—Piroxicam—ALB—melanoma	0.0012	0.183	CrCbGaD
Tenoxicam—Visual disturbance—Docetaxel—melanoma	0.0012	0.0064	CcSEcCtD
Tenoxicam—Hepatitis—Temozolomide—melanoma	0.00118	0.00631	CcSEcCtD
Tenoxicam—Asthenia—Vemurafenib—melanoma	0.00118	0.0063	CcSEcCtD
Tenoxicam—Visual impairment—Carmustine—melanoma	0.00118	0.0063	CcSEcCtD
Tenoxicam—Urinary tract disorder—Temozolomide—melanoma	0.00116	0.00623	CcSEcCtD
Tenoxicam—Cardiac failure—Docetaxel—melanoma	0.00116	0.00622	CcSEcCtD
Tenoxicam—Pruritus—Vemurafenib—melanoma	0.00116	0.00621	CcSEcCtD
Tenoxicam—Urethral disorder—Temozolomide—melanoma	0.00116	0.00619	CcSEcCtD
Tenoxicam—Eye disorder—Carmustine—melanoma	0.00114	0.0061	CcSEcCtD
Tenoxicam—Visual impairment—Temozolomide—melanoma	0.00114	0.00608	CcSEcCtD
Tenoxicam—Erythema—Dactinomycin—melanoma	0.00113	0.00608	CcSEcCtD
Tenoxicam—Gastrointestinal haemorrhage—Docetaxel—melanoma	0.00113	0.00607	CcSEcCtD
Tenoxicam—Anaemia—Bleomycin—melanoma	0.00112	0.00602	CcSEcCtD
Tenoxicam—Diarrhoea—Vemurafenib—melanoma	0.00112	0.006	CcSEcCtD
Tenoxicam—Erythema multiforme—Temozolomide—melanoma	0.00111	0.00597	CcSEcCtD
Tenoxicam—PTGS1—skin of body—melanoma	0.00111	0.0235	CbGeAlD
Tenoxicam—Eye disorder—Temozolomide—melanoma	0.0011	0.0059	CcSEcCtD
Tenoxicam—Cardiac disorder—Temozolomide—melanoma	0.00109	0.00586	CcSEcCtD
Tenoxicam—Leukopenia—Bleomycin—melanoma	0.00109	0.00583	CcSEcCtD
Tenoxicam—Dizziness—Vemurafenib—melanoma	0.00108	0.0058	CcSEcCtD
Tenoxicam—Angiopathy—Temozolomide—melanoma	0.00107	0.00573	CcSEcCtD
Tenoxicam—Mental disorder—Carmustine—melanoma	0.00107	0.00572	CcSEcCtD
Tenoxicam—Immune system disorder—Temozolomide—melanoma	0.00106	0.0057	CcSEcCtD
Tenoxicam—Erythema—Carmustine—melanoma	0.00106	0.00569	CcSEcCtD
Tenoxicam—Malnutrition—Carmustine—melanoma	0.00106	0.00569	CcSEcCtD
Tenoxicam—PTGS2—skin of body—melanoma	0.00106	0.0225	CbGeAlD
Tenoxicam—Anaemia—Dactinomycin—melanoma	0.00105	0.00562	CcSEcCtD
Tenoxicam—Vomiting—Vemurafenib—melanoma	0.00104	0.00558	CcSEcCtD
Tenoxicam—Rash—Vemurafenib—melanoma	0.00103	0.00553	CcSEcCtD
Tenoxicam—Mental disorder—Temozolomide—melanoma	0.00103	0.00553	CcSEcCtD
Tenoxicam—Dermatitis—Vemurafenib—melanoma	0.00103	0.00553	CcSEcCtD
Tenoxicam—Headache—Vemurafenib—melanoma	0.00103	0.0055	CcSEcCtD
Tenoxicam—Malnutrition—Temozolomide—melanoma	0.00103	0.0055	CcSEcCtD
Tenoxicam—Erythema—Temozolomide—melanoma	0.00103	0.0055	CcSEcCtD
Tenoxicam—Breast disorder—Docetaxel—melanoma	0.00102	0.00548	CcSEcCtD
Tenoxicam—Toxic epidermal necrolysis—Docetaxel—melanoma	0.00102	0.00546	CcSEcCtD
Tenoxicam—Leukopenia—Dactinomycin—melanoma	0.00102	0.00544	CcSEcCtD
Tenoxicam—PTGS1—mammalian vulva—melanoma	0.00101	0.0215	CbGeAlD
Tenoxicam—Anaphylactic shock—Bleomycin—melanoma	0.000993	0.00532	CcSEcCtD
Tenoxicam—Oedema—Bleomycin—melanoma	0.000993	0.00532	CcSEcCtD
Tenoxicam—Anaemia—Carmustine—melanoma	0.000981	0.00526	CcSEcCtD
Tenoxicam—Nausea—Vemurafenib—melanoma	0.000973	0.00521	CcSEcCtD
Tenoxicam—Thrombocytopenia—Bleomycin—melanoma	0.000972	0.00521	CcSEcCtD
Tenoxicam—Leukopenia—Carmustine—melanoma	0.00095	0.00509	CcSEcCtD
Tenoxicam—Anaemia—Temozolomide—melanoma	0.000948	0.00508	CcSEcCtD
Tenoxicam—Anorexia—Bleomycin—melanoma	0.000946	0.00507	CcSEcCtD
Tenoxicam—Angioedema—Temozolomide—melanoma	0.000937	0.00502	CcSEcCtD
Tenoxicam—Oedema—Dactinomycin—melanoma	0.000926	0.00496	CcSEcCtD
Tenoxicam—Vertigo—Temozolomide—melanoma	0.000922	0.00494	CcSEcCtD
Tenoxicam—Leukopenia—Temozolomide—melanoma	0.000918	0.00492	CcSEcCtD
Tenoxicam—Palpitations—Temozolomide—melanoma	0.000907	0.00486	CcSEcCtD
Tenoxicam—Thrombocytopenia—Dactinomycin—melanoma	0.000906	0.00486	CcSEcCtD
Tenoxicam—Dyspnoea—Bleomycin—melanoma	0.000885	0.00474	CcSEcCtD
Tenoxicam—Anorexia—Dactinomycin—melanoma	0.000882	0.00473	CcSEcCtD
Tenoxicam—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000867	0.00465	CcSEcCtD
Tenoxicam—Oedema—Carmustine—melanoma	0.000866	0.00464	CcSEcCtD
Tenoxicam—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000866	0.00464	CcSEcCtD
Tenoxicam—Decreased appetite—Bleomycin—melanoma	0.000863	0.00462	CcSEcCtD
Tenoxicam—Acute coronary syndrome—Docetaxel—melanoma	0.000861	0.00461	CcSEcCtD
Tenoxicam—Myocardial infarction—Docetaxel—melanoma	0.000856	0.00458	CcSEcCtD
Tenoxicam—Dry mouth—Temozolomide—melanoma	0.000854	0.00458	CcSEcCtD
Tenoxicam—Stomatitis—Docetaxel—melanoma	0.000851	0.00456	CcSEcCtD
Tenoxicam—Thrombocytopenia—Carmustine—melanoma	0.000848	0.00454	CcSEcCtD
Tenoxicam—Oedema—Temozolomide—melanoma	0.000837	0.00449	CcSEcCtD
Tenoxicam—Anaphylactic shock—Temozolomide—melanoma	0.000837	0.00449	CcSEcCtD
Tenoxicam—Anorexia—Carmustine—melanoma	0.000826	0.00442	CcSEcCtD
Tenoxicam—Hepatobiliary disease—Docetaxel—melanoma	0.000826	0.00442	CcSEcCtD
Tenoxicam—Nervous system disorder—Temozolomide—melanoma	0.000821	0.0044	CcSEcCtD
Tenoxicam—Thrombocytopenia—Temozolomide—melanoma	0.00082	0.00439	CcSEcCtD
Tenoxicam—Agranulocytosis—Docetaxel—melanoma	0.000815	0.00436	CcSEcCtD
Tenoxicam—Skin disorder—Temozolomide—melanoma	0.000813	0.00436	CcSEcCtD
Tenoxicam—Decreased appetite—Dactinomycin—melanoma	0.000805	0.00431	CcSEcCtD
Tenoxicam—Fatigue—Dactinomycin—melanoma	0.000798	0.00428	CcSEcCtD
Tenoxicam—Anorexia—Temozolomide—melanoma	0.000798	0.00428	CcSEcCtD
Tenoxicam—Urticaria—Bleomycin—melanoma	0.000789	0.00422	CcSEcCtD
Tenoxicam—Hepatitis—Docetaxel—melanoma	0.000784	0.0042	CcSEcCtD
Tenoxicam—Urinary tract disorder—Docetaxel—melanoma	0.000774	0.00415	CcSEcCtD
Tenoxicam—Dyspnoea—Carmustine—melanoma	0.000772	0.00414	CcSEcCtD
Tenoxicam—Urethral disorder—Docetaxel—melanoma	0.000768	0.00412	CcSEcCtD
Tenoxicam—Visual impairment—Docetaxel—melanoma	0.000755	0.00405	CcSEcCtD
Tenoxicam—Decreased appetite—Carmustine—melanoma	0.000753	0.00403	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Carmustine—melanoma	0.000748	0.00401	CcSEcCtD
Tenoxicam—Dyspnoea—Temozolomide—melanoma	0.000746	0.004	CcSEcCtD
Tenoxicam—Erythema multiforme—Docetaxel—melanoma	0.000741	0.00397	CcSEcCtD
Tenoxicam—Constipation—Carmustine—melanoma	0.000741	0.00397	CcSEcCtD
Tenoxicam—Dyspepsia—Temozolomide—melanoma	0.000737	0.00395	CcSEcCtD
Tenoxicam—Eye disorder—Docetaxel—melanoma	0.000732	0.00392	CcSEcCtD
Tenoxicam—Hypersensitivity—Bleomycin—melanoma	0.000731	0.00392	CcSEcCtD
Tenoxicam—Decreased appetite—Temozolomide—melanoma	0.000728	0.0039	CcSEcCtD
Tenoxicam—Cardiac disorder—Docetaxel—melanoma	0.000727	0.0039	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Temozolomide—melanoma	0.000723	0.00387	CcSEcCtD
Tenoxicam—Fatigue—Temozolomide—melanoma	0.000722	0.00387	CcSEcCtD
Tenoxicam—PTGS1—head—melanoma	0.000722	0.0154	CbGeAlD
Tenoxicam—Constipation—Temozolomide—melanoma	0.000716	0.00384	CcSEcCtD
Tenoxicam—Asthenia—Bleomycin—melanoma	0.000712	0.00381	CcSEcCtD
Tenoxicam—Angiopathy—Docetaxel—melanoma	0.000711	0.00381	CcSEcCtD
Tenoxicam—Immune system disorder—Docetaxel—melanoma	0.000708	0.00379	CcSEcCtD
Tenoxicam—Pruritus—Bleomycin—melanoma	0.000702	0.00376	CcSEcCtD
Tenoxicam—PTGS2—head—melanoma	0.00069	0.0147	CbGeAlD
Tenoxicam—Mental disorder—Docetaxel—melanoma	0.000687	0.00368	CcSEcCtD
Tenoxicam—Erythema—Docetaxel—melanoma	0.000682	0.00365	CcSEcCtD
Tenoxicam—Malnutrition—Docetaxel—melanoma	0.000682	0.00365	CcSEcCtD
Tenoxicam—Hypersensitivity—Dactinomycin—melanoma	0.000682	0.00365	CcSEcCtD
Tenoxicam—Urticaria—Temozolomide—melanoma	0.000665	0.00356	CcSEcCtD
Tenoxicam—Asthenia—Dactinomycin—melanoma	0.000664	0.00356	CcSEcCtD
Tenoxicam—Hypersensitivity—Carmustine—melanoma	0.000638	0.00342	CcSEcCtD
Tenoxicam—Diarrhoea—Dactinomycin—melanoma	0.000633	0.00339	CcSEcCtD
Tenoxicam—Vomiting—Bleomycin—melanoma	0.000631	0.00338	CcSEcCtD
Tenoxicam—Anaemia—Docetaxel—melanoma	0.000631	0.00338	CcSEcCtD
Tenoxicam—Rash—Bleomycin—melanoma	0.000626	0.00335	CcSEcCtD
Tenoxicam—Dermatitis—Bleomycin—melanoma	0.000625	0.00335	CcSEcCtD
Tenoxicam—Asthenia—Carmustine—melanoma	0.000622	0.00333	CcSEcCtD
Tenoxicam—Hypersensitivity—Temozolomide—melanoma	0.000617	0.0033	CcSEcCtD
Tenoxicam—Leukopenia—Docetaxel—melanoma	0.000611	0.00327	CcSEcCtD
Tenoxicam—Palpitations—Docetaxel—melanoma	0.000603	0.00323	CcSEcCtD
Tenoxicam—Asthenia—Temozolomide—melanoma	0.000601	0.00322	CcSEcCtD
Tenoxicam—Diarrhoea—Carmustine—melanoma	0.000593	0.00318	CcSEcCtD
Tenoxicam—Pruritus—Temozolomide—melanoma	0.000592	0.00317	CcSEcCtD
Tenoxicam—Nausea—Bleomycin—melanoma	0.00059	0.00316	CcSEcCtD
Tenoxicam—Vomiting—Dactinomycin—melanoma	0.000589	0.00315	CcSEcCtD
Tenoxicam—Rash—Dactinomycin—melanoma	0.000584	0.00313	CcSEcCtD
Tenoxicam—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000577	0.00309	CcSEcCtD
Tenoxicam—Dizziness—Carmustine—melanoma	0.000573	0.00307	CcSEcCtD
Tenoxicam—Diarrhoea—Temozolomide—melanoma	0.000573	0.00307	CcSEcCtD
Tenoxicam—Dry mouth—Docetaxel—melanoma	0.000568	0.00304	CcSEcCtD
Tenoxicam—Anaphylactic shock—Docetaxel—melanoma	0.000557	0.00298	CcSEcCtD
Tenoxicam—Oedema—Docetaxel—melanoma	0.000557	0.00298	CcSEcCtD
Tenoxicam—Dizziness—Temozolomide—melanoma	0.000554	0.00297	CcSEcCtD
Tenoxicam—Vomiting—Carmustine—melanoma	0.000551	0.00295	CcSEcCtD
Tenoxicam—Nausea—Dactinomycin—melanoma	0.00055	0.00295	CcSEcCtD
Tenoxicam—Rash—Carmustine—melanoma	0.000546	0.00293	CcSEcCtD
Tenoxicam—Nervous system disorder—Docetaxel—melanoma	0.000546	0.00293	CcSEcCtD
Tenoxicam—Dermatitis—Carmustine—melanoma	0.000546	0.00292	CcSEcCtD
Tenoxicam—Thrombocytopenia—Docetaxel—melanoma	0.000545	0.00292	CcSEcCtD
Tenoxicam—Headache—Carmustine—melanoma	0.000543	0.00291	CcSEcCtD
Tenoxicam—Skin disorder—Docetaxel—melanoma	0.000541	0.0029	CcSEcCtD
Tenoxicam—Vomiting—Temozolomide—melanoma	0.000532	0.00285	CcSEcCtD
Tenoxicam—Anorexia—Docetaxel—melanoma	0.000531	0.00284	CcSEcCtD
Tenoxicam—Rash—Temozolomide—melanoma	0.000528	0.00283	CcSEcCtD
Tenoxicam—Dermatitis—Temozolomide—melanoma	0.000527	0.00283	CcSEcCtD
Tenoxicam—Headache—Temozolomide—melanoma	0.000525	0.00281	CcSEcCtD
Tenoxicam—Nausea—Carmustine—melanoma	0.000515	0.00276	CcSEcCtD
Tenoxicam—PTGS1—lymph node—melanoma	0.000505	0.0108	CbGeAlD
Tenoxicam—Nausea—Temozolomide—melanoma	0.000497	0.00266	CcSEcCtD
Tenoxicam—Dyspnoea—Docetaxel—melanoma	0.000496	0.00266	CcSEcCtD
Tenoxicam—Dyspepsia—Docetaxel—melanoma	0.00049	0.00263	CcSEcCtD
Tenoxicam—Decreased appetite—Docetaxel—melanoma	0.000484	0.00259	CcSEcCtD
Tenoxicam—PTGS2—lymph node—melanoma	0.000483	0.0103	CbGeAlD
Tenoxicam—Gastrointestinal disorder—Docetaxel—melanoma	0.000481	0.00258	CcSEcCtD
Tenoxicam—Fatigue—Docetaxel—melanoma	0.00048	0.00257	CcSEcCtD
Tenoxicam—Constipation—Docetaxel—melanoma	0.000476	0.00255	CcSEcCtD
Tenoxicam—Hypersensitivity—Docetaxel—melanoma	0.00041	0.0022	CcSEcCtD
Tenoxicam—Asthenia—Docetaxel—melanoma	0.000399	0.00214	CcSEcCtD
Tenoxicam—Pruritus—Docetaxel—melanoma	0.000394	0.00211	CcSEcCtD
Tenoxicam—Diarrhoea—Docetaxel—melanoma	0.000381	0.00204	CcSEcCtD
Tenoxicam—Dizziness—Docetaxel—melanoma	0.000368	0.00197	CcSEcCtD
Tenoxicam—Vomiting—Docetaxel—melanoma	0.000354	0.0019	CcSEcCtD
Tenoxicam—Rash—Docetaxel—melanoma	0.000351	0.00188	CcSEcCtD
Tenoxicam—Dermatitis—Docetaxel—melanoma	0.000351	0.00188	CcSEcCtD
Tenoxicam—Headache—Docetaxel—melanoma	0.000349	0.00187	CcSEcCtD
Tenoxicam—Nausea—Docetaxel—melanoma	0.000331	0.00177	CcSEcCtD
Tenoxicam—PTGS2—Metabolism—UGT2B10—melanoma	7.4e-05	0.0013	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	7.31e-05	0.00129	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	7.29e-05	0.00128	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—CXCL8—melanoma	7.17e-05	0.00126	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—ATM—melanoma	7.07e-05	0.00125	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—melanoma	7.04e-05	0.00124	CbGpPWpGaD
Tenoxicam—PTGS2—C-MYB transcription factor network—MYC—melanoma	7.03e-05	0.00124	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—CDKN1B—melanoma	7e-05	0.00123	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	6.97e-05	0.00123	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—HS3ST5—melanoma	6.88e-05	0.00121	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—CASP3—melanoma	6.86e-05	0.00121	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—IL2—melanoma	6.85e-05	0.00121	CbGpPWpGaD
Tenoxicam—SLC22A8—Transmembrane transport of small molecules—ABCB1—melanoma	6.8e-05	0.0012	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—CCND1—melanoma	6.68e-05	0.00118	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—APC—melanoma	6.62e-05	0.00117	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—PLCB4—melanoma	6.57e-05	0.00116	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—EGF—melanoma	6.55e-05	0.00115	CbGpPWpGaD
Tenoxicam—PTGS2—C-MYB transcription factor network—KRAS—melanoma	6.5e-05	0.00115	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—MMP9—melanoma	6.49e-05	0.00114	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—FASN—melanoma	6.45e-05	0.00114	CbGpPWpGaD
Tenoxicam—PTGS1—Selenium Micronutrient Network—IL6—melanoma	6.42e-05	0.00113	CbGpPWpGaD
Tenoxicam—PTGS2—Selenium Micronutrient Network—TNF—melanoma	6.31e-05	0.00111	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—SLC6A11—melanoma	6.17e-05	0.00109	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—PIP4K2A—melanoma	6.17e-05	0.00109	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	6.17e-05	0.00109	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—CUBN—melanoma	6.08e-05	0.00107	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	6.07e-05	0.00107	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—MTAP—melanoma	6.01e-05	0.00106	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	5.87e-05	0.00103	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	5.86e-05	0.00103	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—TRRAP—melanoma	5.85e-05	0.00103	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—CUL3—melanoma	5.85e-05	0.00103	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—AKR1B10—melanoma	5.69e-05	0.001	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—GPAM—melanoma	5.69e-05	0.001	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	5.58e-05	0.000983	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	5.54e-05	0.000976	CbGpPWpGaD
Tenoxicam—PTGS2—C-MYB transcription factor network—HRAS—melanoma	5.52e-05	0.000974	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—MAPK3—melanoma	5.51e-05	0.000971	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—MYC—melanoma	5.36e-05	0.000944	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—ACER3—melanoma	5.36e-05	0.000944	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—LUM—melanoma	5.35e-05	0.000944	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—PHGDH—melanoma	5.35e-05	0.000944	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	5.29e-05	0.000933	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—HPSE—melanoma	5.25e-05	0.000925	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—MAPK1—melanoma	5.24e-05	0.000924	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—EGFR—melanoma	5.24e-05	0.000924	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	5.22e-05	0.00092	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—PLCB4—melanoma	5.21e-05	0.000919	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—CUBN—melanoma	5.15e-05	0.000908	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	5.14e-05	0.000907	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—FASN—melanoma	5.12e-05	0.000902	CbGpPWpGaD
Tenoxicam—PTGS2—Selenium Micronutrient Network—IL6—melanoma	5.09e-05	0.000898	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—LUM—melanoma	5.07e-05	0.000894	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—TNF—melanoma	4.99e-05	0.00088	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—SDHD—melanoma	4.98e-05	0.000877	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—CSPG4—melanoma	4.98e-05	0.000877	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—BSG—melanoma	4.98e-05	0.000877	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—HPSE—melanoma	4.98e-05	0.000877	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—SLC6A11—melanoma	4.9e-05	0.000864	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—PIP4K2A—melanoma	4.9e-05	0.000864	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—UGT2B10—melanoma	4.9e-05	0.000864	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—CUBN—melanoma	4.88e-05	0.000861	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	4.84e-05	0.000853	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—GPAM—melanoma	4.82e-05	0.00085	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—MTAP—melanoma	4.77e-05	0.00084	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	4.76e-05	0.00084	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—CSPG4—melanoma	4.72e-05	0.000831	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	4.67e-05	0.000823	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	4.66e-05	0.000821	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—RPS3—melanoma	4.64e-05	0.000818	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—SKI—melanoma	4.57e-05	0.000805	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—HS3ST5—melanoma	4.56e-05	0.000803	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	4.54e-05	0.000801	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	4.5e-05	0.000793	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—TP53—melanoma	4.4e-05	0.000776	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	4.4e-05	0.000775	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	4.39e-05	0.000773	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	4.37e-05	0.000769	CbGpPWpGaD
Tenoxicam—SLC22A8—Transmembrane transport of small molecules—ALB—melanoma	4.26e-05	0.00075	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—PHGDH—melanoma	4.25e-05	0.000749	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—LUM—melanoma	4.25e-05	0.000749	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—HPSE—melanoma	4.17e-05	0.000735	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—PLA2G6—melanoma	4.1e-05	0.000722	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—CUBN—melanoma	4.09e-05	0.000721	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—IL6—melanoma	4.03e-05	0.00071	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	3.96e-05	0.000698	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—SDHD—melanoma	3.95e-05	0.000696	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—CSPG4—melanoma	3.95e-05	0.000696	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—BSG—melanoma	3.95e-05	0.000696	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—GPAM—melanoma	3.83e-05	0.000674	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—HDAC6—melanoma	3.77e-05	0.000665	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	3.75e-05	0.000661	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—VCAN—melanoma	3.68e-05	0.000649	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	3.67e-05	0.000646	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—melanoma	3.65e-05	0.000642	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—NPPA—melanoma	3.58e-05	0.00063	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	3.57e-05	0.000629	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	3.57e-05	0.000628	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—VCAN—melanoma	3.49e-05	0.000615	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	3.48e-05	0.000614	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—WNT5A—melanoma	3.46e-05	0.00061	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—PLCB4—melanoma	3.45e-05	0.000608	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—melanoma	3.4e-05	0.000598	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—FASN—melanoma	3.39e-05	0.000597	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	3.37e-05	0.000594	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—PPARG—melanoma	3.36e-05	0.000593	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—PLA2G6—melanoma	3.25e-05	0.000573	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—PIP4K2A—melanoma	3.25e-05	0.000572	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—SLC6A11—melanoma	3.25e-05	0.000572	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—MTAP—melanoma	3.16e-05	0.000557	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—CYP17A1—melanoma	3.11e-05	0.000547	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	3.09e-05	0.000545	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	3.09e-05	0.000544	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	3.06e-05	0.00054	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—ALB—melanoma	3.02e-05	0.000533	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—melanoma	2.99e-05	0.000528	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—GNA11—melanoma	2.93e-05	0.000517	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—VCAN—melanoma	2.92e-05	0.000515	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—FASN—melanoma	2.87e-05	0.000506	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—SLC5A5—melanoma	2.82e-05	0.000498	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—PHGDH—melanoma	2.81e-05	0.000496	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—LUM—melanoma	2.81e-05	0.000496	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—GAB2—melanoma	2.78e-05	0.00049	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	2.77e-05	0.000488	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—HPSE—melanoma	2.76e-05	0.000486	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—GNAQ—melanoma	2.73e-05	0.000481	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—CD44—melanoma	2.73e-05	0.000481	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—FASN—melanoma	2.72e-05	0.00048	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—CUBN—melanoma	2.71e-05	0.000477	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.67e-05	0.000471	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—PPARG—melanoma	2.67e-05	0.000471	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	2.65e-05	0.000466	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—SDHD—melanoma	2.62e-05	0.000461	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—BSG—melanoma	2.62e-05	0.000461	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—CSPG4—melanoma	2.62e-05	0.000461	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—CYP1B1—melanoma	2.61e-05	0.000461	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—HDAC2—melanoma	2.61e-05	0.000461	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—FOXO4—melanoma	2.61e-05	0.000461	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—CXCR4—melanoma	2.61e-05	0.000461	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—CD44—melanoma	2.58e-05	0.000456	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—GPAM—melanoma	2.53e-05	0.000447	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	2.53e-05	0.000446	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—CYP17A1—melanoma	2.47e-05	0.000435	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	2.43e-05	0.000429	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—ALB—melanoma	2.4e-05	0.000423	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—AKT3—melanoma	2.39e-05	0.00042	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—GNA11—melanoma	2.33e-05	0.00041	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.31e-05	0.000407	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—FASN—melanoma	2.28e-05	0.000402	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—SLC5A5—melanoma	2.24e-05	0.000395	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—GNAQ—melanoma	2.16e-05	0.000382	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—CD44—melanoma	2.16e-05	0.000382	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—PLA2G6—melanoma	2.15e-05	0.00038	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—ABCB1—melanoma	2.15e-05	0.000379	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.12e-05	0.000374	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—ERBB4—melanoma	2.11e-05	0.000371	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—CDKN2B—melanoma	2.09e-05	0.000368	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—CYP1B1—melanoma	2.08e-05	0.000366	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—CD86—melanoma	2.02e-05	0.000356	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—PRKCA—melanoma	1.98e-05	0.000349	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—ERCC2—melanoma	1.97e-05	0.000346	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—FGF1—melanoma	1.96e-05	0.000345	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—VCAN—melanoma	1.94e-05	0.000341	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—PDGFRA—melanoma	1.9e-05	0.000334	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—PRKCA—melanoma	1.88e-05	0.000331	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—ERCC2—melanoma	1.86e-05	0.000328	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—MAP2K2—melanoma	1.84e-05	0.000324	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.83e-05	0.000323	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.83e-05	0.000323	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.77e-05	0.000312	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—TERT—melanoma	1.75e-05	0.000308	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—HLA-A—melanoma	1.75e-05	0.000308	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—RAC1—melanoma	1.74e-05	0.000307	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—ABCB1—melanoma	1.71e-05	0.000301	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—HIF1A—melanoma	1.67e-05	0.000294	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—CYP17A1—melanoma	1.63e-05	0.000288	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.63e-05	0.000287	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.61e-05	0.000284	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	1.59e-05	0.00028	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—PRKCA—melanoma	1.57e-05	0.000277	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—ERCC2—melanoma	1.56e-05	0.000275	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—PIK3CG—melanoma	1.55e-05	0.000274	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—GNA11—melanoma	1.54e-05	0.000272	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—NOS2—melanoma	1.52e-05	0.000268	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—FASN—melanoma	1.51e-05	0.000266	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—NOTCH1—melanoma	1.5e-05	0.000265	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—PPARG—melanoma	1.5e-05	0.000264	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—SLC5A5—melanoma	1.48e-05	0.000262	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—CD80—melanoma	1.47e-05	0.00026	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—KIT—melanoma	1.47e-05	0.000259	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—APC—melanoma	1.47e-05	0.000259	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—EGF—melanoma	1.45e-05	0.000256	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—GNAQ—melanoma	1.43e-05	0.000253	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—CD44—melanoma	1.43e-05	0.000253	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.4e-05	0.000247	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.39e-05	0.000245	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—BRAF—melanoma	1.38e-05	0.000244	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—CYP1B1—melanoma	1.37e-05	0.000242	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—PIK3CD—melanoma	1.36e-05	0.00024	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—ALB—melanoma	1.35e-05	0.000237	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—MAP2K1—melanoma	1.3e-05	0.000229	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—PIK3CD—melanoma	1.29e-05	0.000228	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.29e-05	0.000228	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—FGF2—melanoma	1.24e-05	0.000218	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—PIK3CG—melanoma	1.23e-05	0.000217	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.21e-05	0.000214	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—PIK3CB—melanoma	1.19e-05	0.00021	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—PPARG—melanoma	1.19e-05	0.00021	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—PTGS2—melanoma	1.18e-05	0.000208	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—MDM2—melanoma	1.16e-05	0.000204	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—ERBB2—melanoma	1.14e-05	0.000201	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—ABCB1—melanoma	1.13e-05	0.000199	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—PIK3CB—melanoma	1.13e-05	0.000199	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—CD4—melanoma	1.13e-05	0.000198	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—PIK3CD—melanoma	1.08e-05	0.000191	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—ALB—melanoma	1.07e-05	0.000188	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—CDKN1B—melanoma	1.06e-05	0.000186	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—PRKCA—melanoma	1.04e-05	0.000184	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—ERCC2—melanoma	1.03e-05	0.000182	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—PTEN—melanoma	1.03e-05	0.000181	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—CTNNB1—melanoma	9.99e-06	0.000176	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—CDKN1A—melanoma	9.76e-06	0.000172	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—PTEN—melanoma	9.74e-06	0.000172	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—PIK3CB—melanoma	9.44e-06	0.000166	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—STAT3—melanoma	8.71e-06	0.000154	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—NRAS—melanoma	8.69e-06	0.000153	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	8.56e-06	0.000151	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—MAPK3—melanoma	8.32e-06	0.000147	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—PIK3CG—melanoma	8.16e-06	0.000144	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—PTEN—melanoma	8.16e-06	0.000144	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—MYC—melanoma	8.09e-06	0.000143	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—MAPK1—melanoma	7.92e-06	0.00014	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—EGFR—melanoma	7.92e-06	0.00014	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—PPARG—melanoma	7.87e-06	0.000139	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—KRAS—melanoma	7.48e-06	0.000132	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—PIK3CA—melanoma	7.25e-06	0.000128	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—PIK3CD—melanoma	7.17e-06	0.000126	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—ALB—melanoma	7.08e-06	0.000125	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—PIK3CA—melanoma	6.87e-06	0.000121	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—HRAS—melanoma	6.36e-06	0.000112	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—PIK3CB—melanoma	6.25e-06	0.00011	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—PTGS2—melanoma	6.19e-06	0.000109	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—IL6—melanoma	6.08e-06	0.000107	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—AKT1—melanoma	5.92e-06	0.000104	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—PIK3CA—melanoma	5.75e-06	0.000101	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—AKT1—melanoma	5.61e-06	9.89e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—PTEN—melanoma	5.4e-06	9.52e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—AKT1—melanoma	4.7e-06	8.29e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—PIK3CA—melanoma	3.81e-06	6.72e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—AKT1—melanoma	3.11e-06	5.49e-05	CbGpPWpGaD
